New York, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Beta-Thalassemia Market Insights, Epidemiology, and Market Forecast ...

Around 5.2% of the global population carries abnormal hemoglobin genes [1]. Each year, 300,000 to 500,000 children are born with severe hemoglobinopathies worldwide, with approximately 80% of these ...

DUBLIN--(BUSINESS WIRE)--The "US Thalassemia Market and Competitive Landscape - 2018" report has been added to ResearchAndMarkets.com's offering. US Thalassemia Market and Competitive Landscape - 2018 ...

This article includes an interview with Dr. Androulla Eleftheriou, Executive Director at TIF, and Dr. Zhiyu Peng, Deputy GM at BGI Genomics, Head of the World Hemoglobinopathy Foundation Thalassemia, ...

Thalassemia is a genetic disorder that is due to mutations of the genes that are responsible for the production of hemoglobin in the blood. Image Credit: Ody_Stocker / Shutterstock.com As one of the ...

On January 21st, the Thalassemia International Federation (TIF) and BGI Genomics jointly hosted an educational webinar focused on thalassemia prevention in high-prevalence regions. The event featured ...

5.2% of the global population carry hemoglobin abnormalities, resulting in 300,000 to 400,000 children born with severe hemoglobinopathies annually. Thalassemia, a hereditary hemoglobinopathy, occurs ...

LONDON--(BUSINESS WIRE)--Technavio analysts forecast the global thalassemia drugs market to grow at a CAGR of close to 10% during the forecast period, according to their latest market research report.

—The global burden of thalassemia has had geographic and demographic shifts in disease distribution over 30 years, with an overall decrease in burden, but an increase in cases among the elderly ...

New York, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Beta-thalassemia Epidemiology Forecast to 2030" - https://www ...